Publications Welcome to Enlighten Publications. View the latest additions to the repository, browse by category or search for specific publications here.

Browse by Journal

[up] Up a level
[Atom feed] Atom [RSS feed] RSS 1.0 [RSS2 feed] RSS 2.0
Number of items: 67.

Pellicori, Pierpaolo ORCID logoORCID: https://orcid.org/0000-0001-7175-0464, Mentz, Robert J. and Lala, Anuradha (2025) August: time to pause—with a purpose. Journal of Cardiac Failure, (Accepted for Publication)

Greene, S. J. et al. (2025) Cardiovascular and renal treatment in heart failure patients with hyperkalemia or high risk of hyperkalemia: rationale and design of the CARE-HK in HF registry. Journal of Cardiac Failure, 31(6), pp. 881-891. (doi: 10.1016/j.cardfail.2024.08.048) (PMID:39277029)

Jering, K. S. et al. (2025) NT-proBNP in the early convalescent phase after high-risk myocardial infarction is associated with adverse cardiovascular outcomes: the PARADISE-MI trial. Journal of Cardiac Failure, (doi: 10.1016/j.cardfail.2025.03.018) (PMID:40250826) (In Press)

Docherty, K. F. et al. (2025) Wearable accelerometer-derived measures of physical activity in heart failure: insights from the DETERMINE trials. Journal of Cardiac Failure, 31(4), pp. 689-703. (doi: 10.1016/j.cardfail.2024.10.439) (PMID:39603408)

Cuthbert, J. J., Cleland, J. G. F. ORCID logoORCID: https://orcid.org/0000-0002-1471-7016, Pellicori, P. ORCID logoORCID: https://orcid.org/0000-0001-7175-0464 and Clark, A. L. (2025) Natriuresis-guided diuresis in patients admitted to hospital with heart failure: barking up the wrong tree? Journal of Cardiac Failure, 31(2), pp. 465-468. (doi: 10.1016/j.cardfail.2024.09.021) (PMID:39637969)

Masri, A. et al. (2024) Efficacy and safety of aficamten in symptomatic non-obstructive hypertrophic cardiomyopathy: results from the REDWOOD-HCM trial, cohort 4. Journal of Cardiac Failure, 30(11), pp. 1439-1448. (doi: 10.1016/j.cardfail.2024.02.020) (PMID:38493832)

Reza, Nosheen, Pellicori, Pierpaolo ORCID logoORCID: https://orcid.org/0000-0001-7175-0464 and Starling, Randall C. (2024) REVOLUTION in heart failure care and SELECT highlights from the European Society of Cardiology-Heart Failure Association Heart Failure and World Congress on Acute Heart Failure 2024. Journal of Cardiac Failure, 30(9), pp. 1157-1160. (doi: 10.1016/j.cardfail.2024.05.004) (PMID:38838982)

Ray, R. et al. (2024) The impact of ferric derisomaltose on cardiovascular and non-cardiovascular events in patients with anemia, iron deficiency and heart failure with reduced ejection fraction. Journal of Cardiac Failure, 30(5), pp. 682-690. (doi: 10.1016/j.cardfail.2023.10.006) (PMID:37926238) (PMCID:PMC11096866)

Buendia, Ruben, Karpefors, Martin, Folkvaljon, Folke, Hunter, Robert, Sillen, Henrik, Luu, Long, Docherty, Kieran ORCID logoORCID: https://orcid.org/0000-0002-5446-9969 and Cowie, Martin R. (2024) Wearable sensors to monitor physical activity in heart failure clinical trials: state-of-the-art review. Journal of Cardiac Failure, 30(5), pp. 703-716. (doi: 10.1016/j.cardfail.2024.01.016) (PMID:38452999)

Monzo, L. et al. (2024) High risk of stroke in patients with worsening heart failure, reduced ejection fraction, coronary heart disease and sinus rhythm: risk prediction score analysis from the COMMANDER-HF trial. Journal of Cardiac Failure, 30(4), pp. 618-623. (doi: 10.1016/j.cardfail.2023.11.020) (PMID:38122924)

Butt, J. H. et al. (2024) Heart failure, investigator-reported sleep apnea and dapagliflozin: A patient-level pooled meta-analysis of DAPA-HF and DELIVER. Journal of Cardiac Failure, 30(3), pp. 436-448. (doi: 10.1016/j.cardfail.2023.08.027) (PMID:38104937)

Docherty, K. F. et al. (2024) The effect of omecamtiv mecarbil in hospitalized patients as compared with outpatients with HFrEF: an analysis of GALACTIC-HF. Journal of Cardiac Failure, 30(1), pp. 26-35. (doi: 10.1016/j.cardfail.2023.08.020) (PMID:37683911)

Owens, A. et al. (2023) Aficamten for drug-refractory severe obstructive hypertrophic cardiomyopathy in patients receiving Disopyramide: REDWOOD-HCM Cohort 3. Journal of Cardiac Failure, 29(11), pp. 1576-1582. (doi: 10.1016/j.cardfail.2023.07.003) (PMID:37473912)

Ostrominski, J. W. et al. (2023) Duration of heart failure with preserved ejection fraction and outcomes with sacubitril/valsartan: insights from the PARAGON-HF trial. Journal of Cardiac Failure, 29(11), pp. 1494-1503. (doi: 10.1016/j.cardfail.2023.05.003) (PMID:37220823)

Biering-Sørensen, T. et al. (2023) The effect of sacubitril/valsartan on left ventricular myocardial deformation in heart failure with preserved ejection fraction (PARAMOUNT trial). Journal of Cardiac Failure, 29(6), pp. 968-973. (doi: 10.1016/j.cardfail.2023.03.019) (PMID:37031887)

Packer, Milton and Cleland, John G.F. ORCID logoORCID: https://orcid.org/0000-0002-1471-7016 (2023) Combining iron supplements with SGLT2 inhibitor-stimulated erythropoiesis in heart failure: should we be worried about thromboembolic events? Journal of Cardiac Failure, 29(3), pp. 403-406. (doi: 10.1016/j.cardfail.2022.12.007) (PMID:36563739)

Manla, Yosef, Kuan, William, Clark, Andrew L., Cleland, John G. F. ORCID logoORCID: https://orcid.org/0000-0002-1471-7016 and Pellicori, Pierpaolo ORCID logoORCID: https://orcid.org/0000-0001-7175-0464 (2023) Ketone bodies in acute heart failure: fuel for thought. Journal of Cardiac Failure, 29(1), pp. 42-44. (doi: 10.1016/j.cardfail.2022.11.002) (PMID:36402423)

Mayne, Kaitlin J., Shemilt, Richard, Keane, David F., Lees, Jennifer S. ORCID logoORCID: https://orcid.org/0000-0001-6331-0178, Mark, Patrick B. ORCID logoORCID: https://orcid.org/0000-0003-3387-2123 and Herrington, William G. (2022) Bioimpedance indices of fluid overload and cardiorenal outcomes in heart failure and chronic kidney disease: a systematic review. Journal of Cardiac Failure, 28(11), pp. 1628-1641. (doi: 10.1016/j.cardfail.2022.08.005) (PMID:36038013)

Thorvaldsen, Tonje, Ferrannini, Giulia, Mellbin, Linda, Benson, Lina, Cosentino, Francesco, McMurray, John J.V. ORCID logoORCID: https://orcid.org/0000-0002-6317-3975, Dahlström, Ulf, Lund, Lars H. and Savarese, Gianluigi (2022) Eligibility for dapagliflozin and empagliflozin in a real-world heart failure population. Journal of Cardiac Failure, 28(7), pp. 1050-1062. (doi: 10.1016/j.cardfail.2022.04.011) (PMID:35550428)

Verdonschot, J. A.J. et al. (2022) The effect of spironolactone in patients with obesity at risk for heart failure: proteomic insights from the HOMAGE trial. Journal of Cardiac Failure, 28(5), pp. 778-786. (doi: 10.1016/j.cardfail.2021.12.005) (PMID:34933097)

Sundaram, V. et al. (2022) Hospitalization for heart failure in the USA, UK, Taiwan and Japan: an international comparison of administrative health records on 417,385 individual patients. Journal of Cardiac Failure, 28(3), pp. 353-366. (doi: 10.1016/j.cardfail.2021.08.024) (PMID:34634448)

Lam, P. H. et al. (2022) Right ventricular ejection fraction and beta-blocker effect in heart failure with reduced ejection fraction: Beta-blocker and outcomes in HFrEF by RVEF. Journal of Cardiac Failure, 28(1), pp. 65-70. (doi: 10.1016/j.cardfail.2021.07.026) (PMID:34419597)

Bhatt, Ankeet S., Claggett, Brian L., Packer, Milton, Lefkowitz, Martin P., Zile, Michael R., McMurray, John J.V. ORCID logoORCID: https://orcid.org/0000-0002-6317-3975, Solomon, Scott D. and Vaduganathan, Muthiah (2021) Treatment effects of sacubitril/valsartan compared with valsartan in patients with recent hospitalization. Journal of Cardiac Failure, 27(9), pp. 1027-1030. (doi: 10.1016/j.cardfail.2021.05.020) (PMID:34133969)

Markousis-Mavrogenis, G. et al. (2021) The additive prognostic value of serial plasma interleukin-6 levels over changes in brain natriuretic peptide in patients with acute heart failure. Journal of Cardiac Failure, 27(7), pp. 808-811. (doi: 10.1016/j.cardfail.2021.01.008) (PMID:33497808)

Pan, Daniel, Pellicori, Pierpaolo ORCID logoORCID: https://orcid.org/0000-0001-7175-0464, Walklett, Claire, Green, Andrew, Masse, Anais R., Wood, Jason, Purdy, Jon and Clark, Andrew L (2020) Driving habits and reaction times on a driving simulation in older drivers with chronic heart failure. Journal of Cardiac Failure, 26(7), pp. 555-563. (doi: 10.1016/j.cardfail.2020.04.002) (PMID:32433933)

Avtaar Singh, Sanjeet Singh, Das De, Sudeep, Rushton, Sally, Berry, Colin ORCID logoORCID: https://orcid.org/0000-0002-4547-8636 and Al-Attar, Nawwar (2019) PREDICTA: a model to predict primary graft dysfunction after adult heart transplantation in the United Kingdom. Journal of Cardiac Failure, 25(12), pp. 971-977. (doi: 10.1016/j.cardfail.2019.07.009) (PMID:31330297)

Beldhuis, I. E. et al. (2019) Trajectories of changes in renal function in patients with acute heart failure. Journal of Cardiac Failure, 25(11), pp. 866-874. (doi: 10.1016/j.cardfail.2019.07.004) (PMID:31319165)

Grodin, J. L. et al. (2019) Prognostic implications of changes in amino-terminal pro–B-type natriuretic peptide in acute decompensated heart failure: insights from ASCEND-HF. Journal of Cardiac Failure, 25(9), pp. 703-711. (doi: 10.1016/j.cardfail.2019.04.002) (PMID:30953792)

Welsh, Paul ORCID logoORCID: https://orcid.org/0000-0002-7970-3643, Papacosta, Olia, Ramsay, Sheena, Whincup, Peter, McMurray, John ORCID logoORCID: https://orcid.org/0000-0002-6317-3975, Wannamethee, Goya and Sattar, Naveed ORCID logoORCID: https://orcid.org/0000-0002-1604-2593 (2019) High sensitivity troponin T and incident heart failure in older men: British Regional Heart Study. Journal of Cardiac Failure, 25(4), pp. 230-237. (doi: 10.1016/j.cardfail.2018.08.002) (PMID:30103019) (PMCID:PMC7083232)

Grodin, J. L. et al. (2018) Circulating cardiac troponin I levels measured by a novel highly sensitive assay in acute decompensated heart failure: insights from the ASCEND-HF trial. Journal of Cardiac Failure, 24(8), pp. 512-519. (doi: 10.1016/j.cardfail.2018.06.008) (PMID:30012361)

Cannon, Jane A., Moffitt, Peter, Perez-Moreno, Ana Cristina, Walters, Matthew R. ORCID logoORCID: https://orcid.org/0000-0001-5743-5871, Broomfield, Niall M., McMurray, John J.V. ORCID logoORCID: https://orcid.org/0000-0002-6317-3975 and Quinn, Terence J. ORCID logoORCID: https://orcid.org/0000-0003-1401-0181 (2017) Cognitive impairment and heart failure: systematic review and meta-analysis. Journal of Cardiac Failure, (doi: 10.1016/j.cardfail.2017.04.007) (PMID:28433667)

Matsue, Y. et al. (2017) Clinical correlates and prognostic value of proenkephalin in acute and chronic heart failure. Journal of Cardiac Failure, 23(3), pp. 231-239. (doi: 10.1016/j.cardfail.2016.09.007) (PMID:27663098)

Gandhi, P. U. et al. (2017) Prognostic value of insulin-like growth factor-binding protein 7 in patients with heart failure and preserved ejection fraction. Journal of Cardiac Failure, 23(1), pp. 20-28. (doi: 10.1016/j.cardfail.2016.06.006) (PMID:27317843)

Cotter, G. et al. (2016) Predictors and associations with outcomes of length of hospital stay in patients with acute heart failure: results from VERITAS. Journal of Cardiac Failure, 22(10), pp. 815-822. (doi: 10.1016/j.cardfail.2015.12.017) (PMID:26721775)

Whellan, David J., Stebbins, Amanda, Hernandez, Adrian F., Ezekowitz, Justin A., McMurray, John J.V. ORCID logoORCID: https://orcid.org/0000-0002-6317-3975, Mather, Paul J., Hasselblad, Vic and O'Connor, Christopher M. (2016) Dichotomous relationship between age and 30-day death or rehospitalization in heart failure patients admitted with acute decompensated heart failure: results from the ASCEND-HF trial. Journal of Cardiac Failure, 22(6), pp. 409-416. (doi: 10.1016/j.cardfail.2016.02.011) (PMID:26952241)

Dalzell, Jonathan R., Rocchiccioli, John P., Weir, Robin A.P., Jackson, Colette E., Padmanabhan, Neal, Gardner, Roy S., Petrie, Mark C. ORCID logoORCID: https://orcid.org/0000-0002-6333-9496 and McMurray, John J.V. ORCID logoORCID: https://orcid.org/0000-0002-6317-3975 (2015) The emerging potential of the apelin-APJ system in heart failure. Journal of Cardiac Failure, 21(6), pp. 489-498. (doi: 10.1016/j.cardfail.2015.03.007) (PMID:25795508)

Metra, M. et al. (2015) Acute heart failure in the elderly: differences in clinical characteristics, outcomes, and prognostic factors in the VERITAS Study. Journal of Cardiac Failure, 21(3), pp. 179-88. (doi: 10.1016/j.cardfail.2014.12.012) (PMID:25573829)

Ueland, Thor, Aukrust, Pål, Nymo, Ståle H., Kjekshus, John, McMurray, John J.V. ORCID logoORCID: https://orcid.org/0000-0002-6317-3975, Wikstrand, John, Block, Dirk, Zaugg, Christian and Gullestad, Lars (2015) Novel extracellular matrix biomarkers as predictors of adverse outcome in chronic heart failure: association between biglycan and response to statin therapy in the CORONA trial. Journal of Cardiac Failure, 21(2), pp. 153-9. (doi: 10.1016/j.cardfail.2014.10.016) (PMID:25451704)

Chin, M. P. et al. (2014) Risk factors for heart failure in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methyl. Journal of Cardiac Failure, 20(12), pp. 953-958. (doi: 10.1016/j.cardfail.2014.10.001) (PMID:25307295)

Li, Yanhong, Levy, Wayne C., Neilson, Matthew P., Ellis, Stephen J., Whellan, David J., Schulman, Kevin A., O'Connor, Christopher M. and Reed, Shelby D. (2014) Associations between Seattle Heart Failure Model scores and medical resource use and costs: findings from HF-ACTION. Journal of Cardiac Failure, 20(8), pp. 541-547. (doi: 10.1016/j.cardfail.2014.05.009) (PMID:24887579)

Kalogeropoulos, A. P. et al. (2014) High-sensitivity C-reactive protein in acute heart failure: insights from the ASCEND-HF trial. Journal of Cardiac Failure, 20(5), pp. 319-326. (doi: 10.1016/j.cardfail.2014.02.002) (PMID:24530944)

Damy, T. et al. (2012) Prevalence of, associations with, and prognostic value of Tricuspid Annular Plane Systolic Excursion (TAPSE) among out-patients referred for the evaluation of heart failure. Journal of Cardiac Failure, 18(3), pp. 216-225. (doi: 10.1016/j.cardfail.2011.12.003) (PMID:22385942)

Weir, R.A.P., Clements, S., Steedman, T., Dargie, H.J., McMurray, J.J.V. ORCID logoORCID: https://orcid.org/0000-0002-6317-3975, Squire, I.B. and Ng, L.L. (2011) Plasma TIMP-4 Predicts Left Ventricular Remodeling After Acute Myocardial Infarction. Journal of Cardiac Failure, 17(6), pp. 465-471. (doi: 10.1016/j.cardfail.2011.02.002)

McKelvie, R.S., Komajda, M., McMurray, J. ORCID logoORCID: https://orcid.org/0000-0002-6317-3975, Zile, M., Ptaszynska, A., Donovan, M., Carson, P. and Massie, B.M. (2010) Baseline Plasma NT-proBNP and Clinical Characteristics: Results From the Irbesartan in Heart Failure With Preserved Ejection Fraction Trial. Journal of Cardiac Failure, 16(2), pp. 128-134. (doi: 10.1016/j.cardfail.2009.09.007)

Carson, P. et al. (2008) Health related quality of life in I-PRESERVE trial. Journal of Cardiac Failure, 14(6), S73. (doi: 10.1016/j.cardfail.2008.06.200)

Wynn, Gareth J., Rammohan, Harish Seetha, Stephens, Barbara, Hawkins, Nathaniel M., McMurray, John J.V. ORCID logoORCID: https://orcid.org/0000-0002-6317-3975 and Rodrigues, Erwin (2008) How many patients with heart failure are suitable for combination ACE inhibitor and candesartan therapy? Journal of Cardiac Failure, 14(6), S114. (doi: 10.1016/j.cardfail.2008.06.397)

Goode, Kevin M., Nabb, Samantha, Cleland, John G.F. ORCID logoORCID: https://orcid.org/0000-0002-1471-7016 and Clark, Andrew L. (2008) A comparison of patient and physician-rated New York Heart Association class in a community-based heart failure clinic. Journal of Cardiac Failure, 14(5), pp. 379-387. (doi: 10.1016/j.cardfail.2008.01.014) (PMID:18514929)

Radauceanu, A. et al. (2008) Extracellular Matrix Turnover and Inflammatory Markers Independently Predict Functional Status and Outcome in Chronic Heart Failure. Journal of Cardiac Failure, 14(6), pp. 467-474. (doi: 10.1016/j.cardfail.2008.02.014)

Cleland, J. et al. (2008) The Selective Cardiac Myosin Activator, CK-1827452, Increases Systolic Function in a Concentration-Dependent Manner in Patients with Stable Heart Failure (10/8/08). Journal of Cardiac Failure, 14(9), pp. 797-798.

White, M. et al. (2007) Effects of combined candesartan and ACE inhibitors on BNP, markers of inflammation and oxidative stress, and glucose regulation in patients with symptomatic heart failure. Journal of Cardiac Failure, 13(2), pp. 86-94. (doi: 10.1016/j.cardfail.2006.10.013)

Massie, Barry, Carson, Peter, Komajda, Michel, McKelvie, Robert, McMurray, John ORCID logoORCID: https://orcid.org/0000-0002-6317-3975, Zile, Michael, Frangin, Gerald and Ptaszynska, Agata (2006) The baseline characteristics of patients enrolled in the irbesartan in heart failure with preserved systolic function trial are similar to those in the community but differ from charm-preserved. Journal of Cardiac Failure, 12(6), S77. (doi: 10.1016/j.cardfail.2006.06.262)

MacDonald, Michael R., Hawkins, Nathaniel M., McMurray, John J.V. ORCID logoORCID: https://orcid.org/0000-0002-6317-3975, Dargie, Henry J. and Petrie, Mark C. ORCID logoORCID: https://orcid.org/0000-0002-6333-9496 (2006) Is CHARM-added candesartan tolerated in 'real-life” patients with advanced chronic heart failure? Journal of Cardiac Failure, 12(6), S126. (doi: 10.1016/j.cardfail.2006.06.434)

Young, J.B. et al. (2006) Reduction of events with darbepoetin alfa in heart failure (RED-HF)™ trial. Journal of Cardiac Failure, 12(6), S77. (doi: 10.1016/j.cardfail.2006.06.264)

Verma, A., Anavekar, N.S., Meris, A., Thune, J.J., Arnold, J.M.O., Ghali, J.K., Velazquez, E.J., McMurray, J.J.V. ORCID logoORCID: https://orcid.org/0000-0002-6317-3975, Pfeffer, M.A. and Solomon, S.D. (2006) Renal function and cardiac structure and function following MI: the VALIANT echo study. Journal of Cardiac Failure, 12(6), S26. (doi: 10.1016/j.cardfail.2006.06.093)

Stewart, Simon and McMurray, John J.V. ORCID logoORCID: https://orcid.org/0000-0002-6317-3975 (2006) Chilling findings: The need for winter vigilance in heart failure. Journal of Cardiac Failure, 12(2), pp. 120-121. (doi: 10.1016/j.cardfail.2005.12.004) (PMID:16520259)

Packer, M. et al. (2005) Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: Results of a pilot study. Journal of Cardiac Failure, 11, pp. 12-20. (doi: 10.1016/j.cardfail.2004.05.006)

Carson, P, Massie, BM, McKelvie, R, McMurray, J ORCID logoORCID: https://orcid.org/0000-0002-6317-3975, Komajda, M, Zile, M, Ptaszynska, A, Frangin, G and Investigators, IP (2005) The Irbesartan in Heart Failure with Preserved Systolic Function (I-PRESERVE) trial: Rationale and design. Journal of Cardiac Failure, 11, pp. 576-585. (doi: 10.1016/j.cardfail.2005.06.432)

Gardner, R.S., Chong, K.S., Morton, J.J. and McDonagh, T.A. (2005) N-terminal brain natriuretic peptide, but not anemia, is a powerful predictor of mortality in advanced heart failure. Journal of Cardiac Failure, 11(5), pp. 47-53. (doi: 10.1016/j.cardfail.2005.04.008)

Zelenkofske, S., McMurray, J.J.V. ORCID logoORCID: https://orcid.org/0000-0002-6317-3975, Califf, R.M., Rouleau, J.L., Pfeffer, M.A., Ertl, G., Harsanyi, A. and Solomon, S.D. (2004) Do sudden cardiac death rates warrant earlier treatment following myocardial infarction? experience from the VALIANT Trial. Journal of Cardiac Failure, 10(4), S71. (doi: 10.1016/j.cardfail.2004.06.196)

Lewis, E.F. et al. (2004) Heart failure post-myocardial infarction in the new millennium: how often does it occur, can we predict it, and what are the consequences? Journal of Cardiac Failure, 10(4), S101. (doi: 10.1016/j.cardfail.2004.06.309)

Kober, L., Maggioni, A.P., McMurray, J.J. ORCID logoORCID: https://orcid.org/0000-0002-6317-3975, Velazquez, E.J., Zelenkofske, S., Zannad, F., Van de Werf, F. and Swedberg, K. (2004) Increased risk of both mortality and morbidity with prior as well as current atrial fibrillation after MI: results of VALIANT. Journal of Cardiac Failure, 10(4), S100. (doi: 10.1016/j.cardfail.2004.06.305)

Tang, W.H.Wilson, Velazquez, E.J., Kilaru, R., Maroo, A., White, H., Kober, L., Rouleau, J.L., McMurray, J.J.V. ORCID logoORCID: https://orcid.org/0000-0002-6317-3975, Califf, R.M. and Francis, G.S. (2004) Patterns and outcomes of revascularization in patients with heart failure and/or left ventricular systolic dysfunction following acute myocardial infarction: observations from the VALIANT registry. Journal of Cardiac Failure, 10(4), S104. (doi: 10.1016/j.cardfail.2004.06.321)

Maggioni, A.P., McMurray, J.J.V. ORCID logoORCID: https://orcid.org/0000-0002-6317-3975, Rouleau, J.L., Velazquez, E.J., Califf, R.M., White, H., Opolski, G. and Pfeffer, M.A. (2004) Who is at risk of early hypotension and renal dysfunction with an inhibitor of the renin angiotensin system after myocardial infarction? data from VALIANT. Journal of Cardiac Failure, 10(4), S89-S90. (doi: 10.1016/j.cardfail.2004.06.262)

Hood, WB, Dans, AL, Guyatt, GH, Jaeschke, R and McMurray, JJV ORCID logoORCID: https://orcid.org/0000-0002-6317-3975 (2004) Digitalis for treatment of congestive heart failure in patients in sinus rhythm: A systematic review and meta-analysis. Journal of Cardiac Failure, 10, pp. 155-164. (doi: 10.1016/j.cardfail.2003.12.005)

Velazquez, E.J., Moreira, M., Rouleau, J.L., Swedberg, K., Kvasnicka, J., Marin-Neto, J.A., Manes, C., Pfeffer, M.A. and McMurray, John ORCID logoORCID: https://orcid.org/0000-0002-6317-3975 (2004) Does the gender gap still persist after myocardial infarction? Treatments and outcomes in VALIANT. Journal of Cardiac Failure, 10(4), S114. (doi: 10.1016/j.cardfail.2004.06.357)

Velazquez, E.J., Califf, R.M., White, H., Zelenkofske, S., Francis, G.S., Lewis, E.F., Pfeffer, M.A. and McMurray, J. ORCID logoORCID: https://orcid.org/0000-0002-6317-3975 (2004) Is the combination of valsartan and captopril better than captopril alone in patients with heart failure and left ventricular systolic dysfunction after myocardial infarction? results of VALIANT. Journal of Cardiac Failure, 10(4), S76. (doi: 10.1016/j.cardfail.2004.06.213)

McMurray, JJV ORCID logoORCID: https://orcid.org/0000-0002-6317-3975 (2004) What are the clinical consequences of anemia in patients with chronic heart failure? Journal of Cardiac Failure, 10, S10-S12. (doi: 10.1016/j.cardfail.2004.01.001)

This list was generated on Thu Aug 7 01:53:42 2025 BST.